Found 8 matching trials
Trial of De-Intensified Post-operative Chemoradiation Following Robotic Surgery for HPV-positive Oropharyngeal Cancer PHASE2 This study will enroll patients with HPV-associated oropharyngeal cancer, u...
Show More Status
Active Not Recruiting
Location
Tower Hematology-Oncology
Learn More & Join Trial
Chemotherapy and Locoregional Therapy Trial (Surgery or Radiation) for Patients With Head and Neck Cancer PHASE2 Carboplatin, nab-paclitaxel, and nivolumab combination will be administered...
Show More Location
University of Chicago Medical Center
Learn More & Join Trial
Quarterback 2b - Sequential Therapy With Reduced Dose Chemoradiotherapy for HPV Oropharynx Cancer NA The purpose of this study is to establish the efficacy and toxicity of low ...
Show More Status
Active Not Recruiting
Location
Icahn School of Medicine at Mount Sinai
Learn More & Join Trial
p16+ Oropharyngeal Cancer Radiation Optimization Trial Reducing Elective Treatment Volumes (PROTEcT) NA Volume and Dose De-Intensified Radiotherapy for p16+ Squamous Cell Carcinom...
Show More Location
Tom Baker Cancer Centre
Learn More & Join Trial
PD-1 Blockade Combined With De-intensified Chemoradiotherapy Sparing Concurrent Cisplatin in Nasopharyngeal Carcinoma PHASE3 This is a phase 3, multi-center, randomized controlled trial, with the purp...
Show More Status
Active Not Recruiting
Location
Beijing Cancer Hospital
Learn More & Join Trial
Phase 2 Study of NAI, HPV Vaccine, and Nab-Paclitaxel in HPV-Positive Oropharyngeal Cancer Followed by De-Intensified Radiation Compared With Standard Chemoradiation PHASE2 This Phase 2a/2 study evaluates the safety, tolerability, and efficacy of n...
Show More Location
Multiple Locations
Learn More & Join Trial
Phase II Clinical Trial of De-Intensified Therapy in Human Papilloma Virus (HPV) Associated Oropharyngeal Squamous Cell Carcinoma PHASE2 HPV-associated Oropharyngeal Squamous Cell Carcinoma (OPSCC) is a type of c...
Show More Location
Multiple Locations
Learn More & Join Trial
Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study PHASE2 This phase II trial studies how well lower-dose chemotherapy plus radiation...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial